NRC (National Research) Capex-to-Operating-Income : 0.35 (As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is National Research Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

National Research's Capital Expenditure for the three months ended in Mar. 2025 was $-2.99 Mil. Its Operating Income for the three months ended in Mar. 2025 was $8.60 Mil.

Hence, National Research's Capex-to-Operating-Income for the three months ended in Mar. 2025 was 0.35.

National Research Capex-to-Operating-Income Historical Data

The historical data trend for National Research's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Capex-to-Operating-Income Chart

National Research Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Capex-to-Operating-Income

Get a 7-Day Free Trial

0.10

0.11

0.21

0.39

0.44

National Research Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Capex-to-Operating-Income	Get a 7-Day Free Trial															0.47	0.59	0.20	0.46	0.35

Competitive Comparison of National Research's Capex-to-Operating-Income

For the Health Information Services subindustry, National Research's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

National Research's Capex-to-Operating-Income Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where National Research's Capex-to-Operating-Income falls into.

Save Embed

;

Save Embed

;

National Research Capex-to-Operating-Income Calculation

National Research's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-15.448)	/	35.194
	=	0.44

National Research's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-2.986)	/	8.596
	=	0.35

National Research (NAS:NRC) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

National Research Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of National Research's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

National Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1245 Q Street, Lincoln, NE, USA, 68508

Website

https://www.nrchealth.com

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Executives

Patrick E Beans	director, officer: CFO and Secretary	AMANDLA LLC, 709 PIER 2, LINCOLN NE 68528
Amandla Mk Trust	10 percent owner	C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust	10 percent owner	709 PIER 2, LINCOLN NE 68528
Parul Bhandari	director	1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Penny Ann Wheeler	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Stephen H Lockhart	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch	officer: Vice President and COO
Kevin R Karas	officer: SVP Finance, CFO, Treas & Secy	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009	10 percent owner	C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin	director	6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy	officer: Chief Growth Officer	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson	officer: President	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly	director	P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry	director	P.O. BOX 103115, DENVER CO 80250